Market revenue in 2023 | USD 38.4 million |
Market revenue in 2030 | USD 74.8 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Small molecule |
Fastest growing segment | Large Molecule |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule, Large Molecule |
Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 53.91% in 2023. Horizon Databook has segmented the Singapore bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical industry is increasingly drawn to Singapore due to its high-quality research & innovation, trusted regulatory & IP environment, and good talent base. Singapore has become a hub for healthcare providers & biopharmaceutical producers.
The emerging regional biopharmaceutical & pharmaceutical companies have propelled the demand for CROs. The CROs offer preclinical services providing early-stage research activities, including toxicology, bioanalysis, and safety studies.
The Singapore market is driven by the aging population, surging lifestyle & age-related diseases, demand for strong clinical research activities because of the emergence of new diseases, increasing number of CRO services, rising number of clinical trials, pilot scientific collaborations, and research innovations for better treatment outcomes for patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Singapore bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account